baber/WOPTO huggingface dataset:
Patent CA-3168043-A1 (CA)
Title: Application of punicalagin/ellagic acid to improve oxidative and colloidal stability of beverages (esp. beer)
Inventor: MERTENS TUUR
IPC: A23L2/62
Filed: 2021-02-26
Abstract: The present invention relates to a method for producing a beverage, preferably a fermented beverage with improved oxidative and colloidal stability. The present invention further relates to a beverage produced by a method for producing a beverage. The present invention also relates to a beverage having increased stability, preferably increased oxidative flavor stability and colloidal stability. The present invention further relates to a use of a stabilizing agent for preparing a beverage having increased stability.
Patent CA-3168394-A1 (CA)
Inventor: COOK JAMES
IPC: E21B41/00
Filed: 2022-07-20
Abstract: A high-pressure unit (HPU) skid for greasing and actuating a frac tree valve includes one or more hydraulic pumps, a grease pump, a hydraulic reservoir, and two or more accumulators all of which are mounted on a portable frame. The HPU skid further includes fluidic connections to connect the frac tree valve to an output of the grease pump and fluidic connections to connect the frac tree valve to at least one of the two or more accumulators. The hydraulic pumps are configured to withdraw hydraulic fluid from the hydraulic reservoir for charging the accumulators, operating the grease pump, or charging the accumulators and operating the grease pump at a same time.
Patent CA-3177352-A1 (CA)
Title: Positive pressure breathing circuit
Inventor: LOVE DAVID JOHN
IPC: A61M16/00
Filed: 2022-02-11
Abstract: The present disclosure relates to a positive pressure breathing circuit and a method for ventilating a patient. The breathing circuit can be used in any type of pressurized breathing therapy including, for example, continuous positive air(way) pressure (CPAP) therapy and bilevel positive air pressure therapy where the inspiratory and expiratory pressures differ.
Patent CA-3177853-A1 (CA)
Inventor: MURUGANATHAN SIVA
IPC: H04L5/00
Filed: 2021-04-09
Abstract: L'invention concerne des systèmes et des procédés d'activation d'états TCI et de mise en correspondance entre points de code et états TCI. Le procédé mis en oeuvre par un dispositif sans fil pour activer des états TCI comprend au moins une des étapes suivantes : être configuré pour surveiller une pluralité de formats DCI comportant le champ TCI pour une réception PDSCH; recevoir un MAC CE unique pour activer des états TCI et mettre en correspondance les états TCI activés avec les points de code de champ TCI des formats DCI; et recevoir des MAC CE séparés pour activer les états TCI et mettre en correspondance les états TCI activés avec les points de code de champ TCI de chacun des formats DCI. En tant que tels, les états TCI pour une planification de liaison descendante peuvent être choisis de manière plus souple pour chaque format DCI au moyen de MAC CE séparés. De plus, des définitions d'état TCI par défaut peuvent être fournies lorsqu'une activation d'état et une mise en correspondance d'états et de points de code de champ TCI avec de multiples formats DCI sont fournies par un MAC CE unique ou des MAC CE différents.
Patent CA-3182823-A1 (CA)
Inventor: MOREIRA CORREIA RUI PEDRO
IPC: G01N33/493
Filed: 2020-06-30
Abstract: The present disclosure relates to a strip element configured to be internally or externally, fixedly or removably provided to an absorbent hygiene article, such as a diaper. The strip element comprises at least one sensing element for obtaining excretion-related information in a hygiene article such as a diaper, the sensing element having a capacitor electrode, a signal line, and a ground element such as a ground electrode and/or ground line. The capacitor electrode and the ground element are for measuring an impedance. The capacitor electrode is electrically connected to the signal line. The sensing element further comprises a shielding component provided between the signal line and the ground element. The strip element is configured such that an electric potential of the shielding component synchronously oscillates with an electric potential of the signal line.
Patent CA-3183742-A1 (CA)
Inventor: ENGELKEMIER ANDREW JOHN
IPC: A61G7/002
Filed: 2021-09-29
Abstract: A patient support system is provided for use on a litter of a patient support apparatus. The patient support system includes an expandable patient support and a control assembly connectable to the expandable patient support. The control assembly includes a user interface with a display and a controller configured to display a predetermined sequence of graphical animations on the display to graphically instruct a user to perform a plurality of tasks after the user selects a new width for the expandable patient support on the user interface.
Patent CA-3185458-A1 (CA)
Inventor: YAM ALICE
IPC: A61P35/00
Filed: 2021-06-03
Abstract: Provided are immunoconjugates comprising bispecific anti-MUC 1/EGFR antibodies conjugated to hemiasterlin-based moieties via cleavable linkers, and pharmaceutical compositions thereof. Provided also are methods of treating cancer using such immunoconjugates and pharmaceutical compositions.
Patent CA-3185894-A1 (CA)
Inventor: EYDANI ASL MOHAMAD
IPC: B65D83/70
Filed: 2021-08-05
Abstract: A plastic container (10) for storing a product. The container includes a base (2) formed of a plastic material and sidewalls (4) formed of the plastic material and extending upwardly from the base, ending in an open top adapted to be closed by a cap (6), and with the base defining an interior volume. The container also includes a snapping frame (100) integrally formed in the base of the plastic material. The frame (100) has a convex base shape before activation when the pressure in the interior volume is less than or equal to a predetermined critical pressure and has a concave base shape immediately after activation when the pressure in the interior volume is greater than the predetermined critical pressure, thereby increasing the interior volume and avoiding catastrophic failure of the container. Also disclosed are a method of using the container and a process of manufacturing the container.
Patent CA-3189934-A1 (CA)
Inventor: KADONO YUUICHI
IPC: G05D1/02
Filed: 2021-08-06
Abstract: A first process acquires the location of a boundary between a work area and a dumping area. A second process acquires the current location of a work machine. A third process controls the work machine so as to form a wheel stop when the work machine is traveling from the work area toward the dumping area, by causing work equipment to be raised from a location that is a prescribed distance away from the location of the boundary and is on the work area side.
Patent CA-3190360-A1 (CA)
Title: Modified cas9 system having a dominant negative effector on non-homologous end-joining fused thereto and its use for improved gene editing
Inventor: MUSSOLINO CLAUDIO
IPC: C12N15/90
Filed: 2021-07-26
Abstract: The present invention relates to modified Cas9 nuclease comprising a substantial part of a Cas9 nuclease and fused thereto at least one substantial part of a dominant negative effector on non-homologous end-joining selected from the group consisting of RNF168, 53BP1, Ku80 and DNA-PK which compete with NHEJ promoting factors and CtIP.
Patent CA-3191183-A1 (CA)
Title: Heteroaromatic ring compound as ret kinase inhibitor, and preparation and use thereof
Inventor: ZHU YONGQIANG
IPC: A61K31/437
Filed: 2021-08-19
Abstract: Disclosed are a heteroaromatic ring compound as a RET kinase inhibitor, and the preparation and the use thereof, wherein the compound is a compound having the structure of formula (I) or a pharmaceutically acceptable salt thereof. The compound or a salt thereof can be used for treating or preventing diseases or conditions by targeting receptors of fused and mutated forms of the RET gene, can effectively inhibit the growth of multiple tumor cells, produces an inhibitory effect on a RET gene fusion mutation and other proteases, and can be used for preparing an anti-tumor drug.
Patent CA-3194130-A1 (CA)
Inventor: CHEUNG WAN
IPC: A47C23/00
Filed: 2023-03-24
Abstract: The present application relates to the technology field of iron frame sofa, in particular to an iron frame sofa with a foldable hinge structure. The iron frame sofa includes a sofa mainframe with connecting square tubes mounted at four inner comers of the sofa mainframe. Supporting legs are mounted at bottom of the connecting square tubes. A grille supporting frame is mounted on top of the sofa mainframe. A first assembling pipe seat is mounted on both sides of a back of a inner wall of the sofa mainframe. A first assembling pipe is sleeved with the first assembling pipe seat at top end of the first assembling pipe seat. A second assembling pipe seat is mounted on both of a front and a rear side of a right side of the inner wall of the sofa mainframe. A second assembling pipe is sleeved with the second assembling pipe seat at top end of the second assembling pipe seat. Folding hinges are mounted at both ends of the top of the second and first assembling pipes. The overall structure of the iron frame sofa is simple, and it is convenient to minimize packaging volume by folding the armrest and backrest frame by hinges, which can save space and reduce transportation costs and save packaging materials and have high stability and practicality, having certain promotion value.
Patent CA-3194646-A1 (CA)
Inventor: HALLEN PAUL R
IPC: A61B90/00
Filed: 2021-10-19
Abstract: Outil d'imagerie comportant un instrument tubulaire de diamètre minimal destiné à être localisé dans l'?il d'un patient et à étendre une plate-forme de capture d'image à partir de ce dernier. La plateforme est dimensionnée de manière unique pour un stockage dans la lumière ou dans le diamètre interne de l'instrument, tel qu'un capteur d'image à film mince. Cependant, un boîtier de micropuce ayant un encombrement trop important pour le diamètre interne de l'instrument peut être déplacé vers un autre emplacement de l'outil, par exemple à l'intérieur de la pièce à main ou du boîtier adjacent, plus grand. En outre, la plate-forme peut être étendue lorsqu'elle est exposée à l'intérieur de l'?il par l'extension dans ce dernier. Ainsi, une surface et un nombre de pixels accrus peuvent être fournis pour l'imagerie.
Patent CA-3197194-A1 (CA)
Inventor: WAN YEHUA
IPC: H05B45/325
Filed: 2021-09-08
Abstract: A light dimming system includes a rectifier, a voltage acquisitor, a controller, a driver connected to the controller and the rectifier, a dimmer starter, and a power supplier. The rectifier is used to connect to mains power supply via a switch or a dimmer to convert the input alternating current (AC) into a direct current (DC). The voltage acquisitor is used to receive the DC from the rectifier, obtain status of the mains power supply. The controller is used to generate a driver control signal according to the status of the mains power supply. The driver control signal is an analog control signal or a pulse width modulation (PWM) control signal. The driver generates a corresponding driving current according to the driver control signal to enable the lighting module to emit light. The dimmer starter is configured to turn on the dimmer according to a conduction control signal.
Patent CA-3198796-A1 (CA)
Inventor: HERMANT THOMAS
IPC: C08L27/06
Filed: 2021-11-08
Abstract: La présente invention concerne un procédé de préparation d'un copolymère de chlorure de vinyle et d'un (méth)acrylate, ainsi qu'une composition comprenant un copolymère de chlorure de vinyle et un (méth)acrylate ayant des propriétés souhaitables. En particulier, l'invention concerne un procédé de production d'un copolymère de chlorure de vinyle-(méth)acrylate, C, par mise en réaction d'un monomère de chlorure de vinyle, A, et d'un monomère de (méth)acrylate d'alkyle, B, ledit procédé comprenant : A) au cours d'une première étape : i) la fourniture d'un premier mélange comprenant un monomère de chlorure de vinyle, A, et d'un (méth)acrylate d'alkyle, B, dans un milieu aqueux dans un réacteur, dans lequel : a. la quantité de B est comprise entre 20 et 100 % de la quantité totale de B, b. la quantité de A est comprise entre 15 et 80 % de la quantité totale de A, et c. le rapport en poids de A/B est de 25/75 à 75/25; ii) la polymérisation dudit premier mélange, ladite polymérisation s'effectuant par : a. chauffage du réacteur à une température, T1, b. ajout d'un initiateur pour démarrer la polymérisation, et : c. lorsque la quantité de B au début de la polymérisation est inférieure à 100 % de la quantité totale de B, le reste de B est ajouté au réacteur au cours de cette première étape après l'initiation de la polymérisation, d. lorsque la quantité de A au début de la polymérisation est inférieure à 80 % de la quantité totale de A, éventuellement un autre monomère A est ajouté au réacteur au cours de cette première étape après l'initiation de la polymérisation, mais à condition que la quantité de monomère A ajoutée dans cette première étape reste inférieure à 80 % de la quantité totale de A, et e. la polymérisation se poursuit jusqu'à ce qu'au moins 50 % de la quantité totale de monomère B ait réagi; B) au cours d'une deuxième étape : i) ajout du reste du monomère A pour former un deuxième mélange, et polymérisation du deuxième mélange.
Patent CA-3199822-A1 (CA)
Inventor: KIEZEBRINK HARM
IPC: A01P1/00
Filed: 2021-11-25
Abstract: Des procédés de mise en oeuvre de procédures sanitaires dans un espace défini comprennent : l'introduction dans ledit espace d'une mousse comprenant un agent moussant et un gaz ; de manière complémentaire à l'introduction de la mousse, l'introduction dans ledit espace d'une composition comprenant une quantité efficace de dioxyde de chlore ; et l'admission de la mousse pour remplir suffisamment ledit espace, ce qui permet l'admission de la composition de dioxyde de chlore pour désinfecter suffisamment l'espace et les surfaces de sujets et/ou d'objets présentsdans celui-ci. L'invention concerne également des produits assainissants et/ou désinfectants, comprenant un agent moussant et une composition assainissante et/ou désinfectante aqueuse comprenant du dioxyde de chlore et un système tensioactif d'entretien d'effet.
Patent CA-3201570-A1 (CA)
Title: Photo-curable insulation foam, dispenser for injection thereof, and methods of using same in the insulation
Inventor: WANG YING
IPC: C08F2/50
Filed: 2021-12-07
Abstract: Provided are photo-curable foam-forming compositions, methods of making and using them, and a dispenser for injecting the foam-forming composition for the insulation of buildings. In one aspect, the present disclosure provides for a method of insulating a surface, such as that of a building cavity with an insulating foam, the method comprising: irradiating a foam¬ forming composition with light, the foam-forming composition comprising: a polymerizable component (e.g., based on epoxy or acrylate); an effective amount of a photoinitiator; and a blowing agent; and injecting the irradiated foam-forming composition adjacent the surface.
Patent CA-3203808-A1 (CA)
Inventor: MATSUSHITA SAKI
IPC: A01N43/54
Filed: 2021-11-30
Abstract: Provided is an agrochemical composition that contains a compound represented by formula (I), a salt having herbicidal activity, a surfactant, and water, and that has a pH at 25? that is greater than 3.5 but is less than 8.8.
Patent CA-3207209-A1 (CA)
Title: System of thawing biological materials and method thereof
Inventor: CHAN HO NAM
IPC: C12M3/00
Filed: 2022-01-17
Abstract: Disclosed in the present invention are a thaw recovery system and method for a biomaterial. The system comprises: a carrier, a vessel container, and a chip. A recess is provided at a position of the carrier close to a front end, and a biomaterial to be thawed and a cryoprotectant are contained in the recess; an oil-phase thawing liquid is contained in the vessel container, the recess of the carrier is immersed into the oil-phase thawing liquid, and the oil-phase thawing liquid covers the recess of the carrier and thaws and recovers the biomaterial; a chemical containing the cryoprotectant and/or a basic culture solution is packaged in the chip, the carrier is removed from the oil-phase thawing liquid, and the chip covers the carrier; the chip is moved relative to the carrier, and the chemical makes full coverage contact with the recess to remove the cryoprotectant in the recess. By means of the present application, the whole thaw recovery processing process can be effectively standardized and automated, effective quality control is achieved, processing efficiency is improved, and personnel training requirements are reduced.
Patent CA-3208664-A1 (CA)
Title: Removable visor for a helmet
Inventor: POSTOLEK FILIP
IPC: A42B3/04
Filed: 2022-01-18
Abstract: An apparatus for a helmet including a receiver adapted for connecting with an accessory. The apparatus comprises a visor adapted to releasably connect with the receiver, the visor including a repeater adapted to connect with the accessory when the visor is connected to the receiver. The visor may also be adapted to connect with additional items or accessories aside from via the receiver, such as by including a mounting assembly having a picatinny rail. Related methods are also disclosed.
Patent CA-3209600-A1 (CA)
Title: Systems and methods for authenticating user information
Inventor: LUCIC ROMULUS
IPC: H04L9/32
Filed: 2020-01-03
Abstract: Disclosed herein are efficient systems and methods for verification of user information in a timely manner. A background computer process for verification of the user information using a third-party authentication service is initiated. The third-party authentication service performs the verification of the information submitted by the user in response to some of the questions within the questionnaire at the same time as the user is replying to remaining questions within the electronic questionnaire. Accordingly, by the time the user is finished replying to all questions within the electronic questionnaire, the previously submitted information by the user is verified and a profile of the user is authenticated.
Patent CA-3211506-A1 (CA)
Title: Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer
Inventor: BELINSKY STEVEN A
IPC: A61K9/14
Filed: 2019-02-07
Abstract: An embodiment of the present invention provides for a dry powder pharmaceutical composition suitable for dispersion in an aerosol for inhaled administration to a patient with cancer, the composition comprising: a cytidine analogue including salts, solvates, hydrates, and esters thereof; and a pharmaceutically acceptable excipient together forming the dry powder pharmaceutical composition suitable for dispersion in the aerosol for administration via inhalation to the patient with cancer. Another embodiment provides for a method of making the composition and a further embodiment provides for a method a treating a patient in need thereof with the composition.
Patent CA-3212023-A1 (CA)
Title: Composition agricole comprenant de la kasugamycine
Inventor: CABALLERO MARIN VIRGILIO VALDES
IPC: A01N43/16
Filed: 2022-02-28
Abstract: La présente divulgation concerne des compositions ou combinaisons agricoles ayant une activité antimicrobienne à large spectre. En particulier, la présente divulgation concerne une composition agricole comprenant de la kasugamycine ou un sel de celle-ci et un éliciteur de résistance des plantes qui présente des propriétés antifongiques et antibactériennes. D'autres aspects de la présente divulgation concernent une composition agricole liquide, une formulation agricole prémélangée aqueuse et un procédé de préparation de celle-ci. La présente divulgation concerne en outre un procédé de lutte contre des agents phytopathogènes.
Patent CA-3213579-A1 (CA)
Inventor: ORMSBEE BOWDEN
IPC: F21V21/088
Filed: 2022-03-29
Abstract: A carabiner apparatus includes a carabiner body, the carabiner body having a first portion and a second portion, the first and second portion defined by a G-arm, the first portion including a carabiner opening, the G-arm adjacent to the carabiner opening. The carabiner further includes a first gate, the first gate oriented to close and open the carabiner opening. The carabiner future includes a second gate, the second gate extending from the G-arm to a portion of the carabiner body, the second gate when closed separating the first portion of the carabiner body from the second portion of the carabiner body.
Patent CA-3213620-A1 (CA)
Inventor: PIRON PAUL
IPC: B23K26/364
Filed: 2022-03-08
Abstract: A method for processing a cardboard (12) with a laser beam (14) is provided, wherein the laser beam (14) is moved over the cardboard (12) along a desired folding line (24) such that an upper layer of the cardboard (12) is ablated without cutting through the cardboard (12), wherein the laser beam (14) is adjusted such that the laser beam (14) is focused below the cardboard (12).
Patent CA-3216693-A1 (CA)
Inventor: CONGREVE MILES STUART
IPC: C07D257/04
Filed: 2022-04-22
Abstract: The disclosures herein relate to novel compounds of formula (1): (1) and salts and any tautomers thereof, wherein X, R1 and R2 are defined herein, and their use 5 in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR35 receptors.
Patent CA-3219484-A1 (CA)
Title: Moderateurs epigenetiques de l'efficacite de la naltrexone dans la reduction de la consommation lourde de boisson chez des individus chez lesquels un trouble de l'usage de l'alcool a ete diagnostiqu
Inventor: ANTON RAYMOND F
IPC: C12Q1/6883
Filed: 2022-05-25
Abstract: L'invention concerne un procédé de prédiction de la réponse à la naltrexone chez des sujets atteints d'un trouble de l'usage de l'alcool (AUD). Dans certains modes de réalisation, les procédés comprennent la réalisation ou le fait d'avoir réalisé un ou plusieurs dosages de méthylation sur un échantillon d'ADN génomique isolé du sujet pour déterminer l'état de méthylation d'une ou de plusieurs régions de l'ADN génomique isolé, la ou les régions étant des sous-séquences d'un gène choisi parmi un gène de récepteur opioïde Mu (OPRM1), un gène de catéchol-O-méthyltransférase (COMT) et un gène de transporteur de dopamine (SLC6A3), l'état de méthylation de la ou des régions de l'ADN génomique isolé déterminé étant prédictif de la réponse à la naltrexone chez le sujet. L'invention concerne également une méthode de traitement de patients chez lesquels un AUD a été diagnostiqué avec le médicament à base de naltrexone sur la base d'un état de méthylation d'une combinaison de sites de méthylation spécifiques localisés associés à un gène OPRM1, un gène COMT, et/ou un gène SLC6A3 obtenu à partir de chaque patient atteint d'AUD.
Patent CA-3224526-A1 (CA)
Inventor: ABE NAOMI
IPC: A61K31/519
Filed: 2018-08-31
Abstract: An antitumor agent for treating a malignant tumor patient expressing EGFR having at least one mutation selected from the group consisting of G719X mutation of exon 18, E709X  mutation of exon 18, and L861X mutation of exon 21, wherein X  represents an arbitrary amino-acid residue, the antitumor agent comprising (S)-N-(4-amino-6-methy1-5-(quinolin-3-y1)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide or a salt thereof.